Loading...
•
Jun 30, 2023
GE HealthCare Q2 2023 Earnings Report
GE HealthCare reported its financial results for the second quarter of 2023, showing revenue growth and progress on operating priorities, leading to raised full-year guidance.
Key Takeaways
GE HealthCare's Q2 2023 results showed a 7% increase in revenue, with organic revenue growth of 9%. Net income was $418 million, and adjusted EBIT was $711 million. The company raised its full-year guidance for organic revenue growth and adjusted EPS.
Revenue increased by 7% year-over-year, with 9% organic revenue growth.
Organic orders grew by 6%, reflecting strong global demand.
Net income attributable to GE HealthCare was $418 million.
The company raised full-year guidance for organic revenue growth and adjusted EPS.
GE HealthCare
GE HealthCare
GE HealthCare Revenue by Segment
Revenue by Segment
Imaging Revenue
CapyFin.comPatient Care Solutions Revenue
CapyFin.comPharmaceutical Diagnostics Revenue
CapyFin.comOther Revenue
CapyFin.com Forward Guidance
The Company updated its guidance for full year 2023 with organic revenue growth in the range of 6% to 8% year-over-year and Adjusted EPS in the range of $3.70 to $3.85.
Positive Outlook
- Organic revenue growth in the range of 6% to 8% year-over-year.
- Adjusted EBIT margin in the range of 15.0% to 15.5%.
- Adjusted effective tax rate (ETR) in the range of 23% to 25%.
- Adjusted EPS in the range of $3.70 to $3.85.
- Free cash flow conversion of 85% or more for the full year.
Revenue & Expenses
Visualization of income flow from segment revenue to net income